Benchmark Starts Orgenesis (ORGS) at Speculative Sell
- Nasdaq ends at record high as Big Tech roars back
- Sanderson Farms (SAFM) Explores Sale - Report
- Bitcoin (BTC) Cracks $30,000 to Hit 6-Month Low, Here Are Next Targets Lower
- Dollar lower as Powell reaffirms pledge to not raise rates too quickly
- Splunk (SPLK) Lands $1 Billion From Silver Lake, Announces Buyback One Day After Activist Rumors Surface
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Benchmark analyst Bruce Jackson initiates coverage on Orgenesis (NASDAQ: ORGS) with a Speculative Sell rating.
Shares of Orgenesis closed at $4.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Argus Starts Taiwan Semiconductor Manufacturing Co. Ltd. (TSM) at Buy
- JPMorgan Starts PT Vale Indonesia Tbk (INCO:IJ) (PTNDF) at Overweight
- Stifel Resumes Surgery Partners (SGRY) at Hold
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!